Ikarian Capital, LLC Ocular Therapeutix, Inc Call Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $2.01 Million - $2.97 Million	-206,800 Reduced 29.54%	493,200 $4.93 Million
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $5.88 Million - $8.39 Million	437,900 Added 167.07%	700,000 $9.93 Million
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $791,000 - $1.11 Million	-50,000 Reduced 16.02%	262,100 $4.3 Million
Q4 2020 Feb 12, 2021	BUY	$7.91 - $22.95 $1.28 Million - $3.72 Million	162,100 Added 108.07%	312,100 $6.46 Million
Q4 2019 Jan 31, 2020	BUY	$2.57 - $4.73 $385,500 - $709,500	150,000 New	150,000 $593,000

175

136M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $593M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.